DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Pyridoxal Phosphate is an investigational drug.
There have been 7 clinical trials for Pyridoxal Phosphate. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2011.
The most common disease conditions in clinical trials are Movement Disorders, Dyskinesias, and Protoporphyria, Erythropoietic. The leading clinical trial sponsors are Medicure, Beersheva Mental Health Center, and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Recent Clinical Trials for Pyridoxal Phosphate
|Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency||Medicure||Phase 3|
|Study of Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency||Medicure||Phase 3|
|Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria||Icahn School of Medicine at Mount Sinai||N/A|